Indacaterol
  
Side effects 
	
		
Options: 
			
			Hide MedDRA Preferred Terms
			
		
	
	
| MedDRA Preferred Term | Side effect | Data for drug | Placebo | Labels | 
|  | 1 | 2 | 3 | 
| Upper respiratory tract infection | Upper respiratory tract infection | common, 14.2% |  | x | x | x | 
| Cough | Cough | common, 6.46% - 8.2% | 4.49% | x | x | x | 
| Nasopharyngitis | Nasopharyngitis | common, 5.35% - 14.3% | 2.7% | x | x | x | 
| Rhinorrhoea | common |  |  | x | x | 
| Chest pain | Chest pain | common |  |  | x | x | 
| Chest discomfort |  |  |  |  | x | 
| Dizziness | Dizziness | postmarketing, common |  | x | x | x | 
| Gastrointestinal disorder | Gastrointestinal disorder | common |  | x |  | x | 
| Sinusitis | Sinusitis | common |  | x | x | x | 
| Dry mouth | Dry mouth | common |  |  |  | x | 
| Oedema peripheral | Oedema peripheral | common |  | x | x | x | 
| Malnutrition | Malnutrition | common |  | x | x | x | 
| Throat irritation | Throat irritation | common |  |  | x |  | 
| Rhinorrhoea | Rhinorrhoea | common |  |  | x | x | 
| Oropharyngeal pain | Oropharyngeal pain | common, 2.23% | 0.674% | x | x | x | 
| Headache | Headache | postmarketing — 3.7% - 5.12% | 2.47% | x | x | x | 
| Muscle spasms | Muscle spasms | common, 3.5% |  | x | x | x | 
| Nausea | Nausea | 2.45% | 0.899% | x |  |  | 
| Atrial fibrillation | Atrial fibrillation | uncommon |  | x | x | x | 
| Diabetes mellitus | Diabetes mellitus | uncommon, common |  | x | x | x | 
| Dermatitis | Rash | postmarketing, uncommon |  | x | x | x | 
| Rash | Rash | postmarketing, uncommon |  | x | x | x | 
| Hyperglycaemia | Hyperglycaemia | uncommon, common |  | x | x | x | 
| Hypersensitivity | Hypersensitivity | postmarketing, uncommon |  | x | x |  | 
| Musculoskeletal pain | Musculoskeletal pain | uncommon |  | x | x | x | 
| Palpitations | Palpitations | postmarketing, uncommon |  | x | x | x | 
| Paraesthesia | Paraesthesia | uncommon |  |  | x | x | 
| Pruritus | Pruritus | postmarketing, uncommon |  | x | x | x | 
| Tachycardia | Tachycardia | postmarketing, uncommon |  | x | x | x | 
| Myocardial ischaemia | Myocardial ischaemia | uncommon |  |  | x | x | 
| Myalgia | Myalgia | uncommon |  |  | x | x | 
| Musculoskeletal discomfort | Myalgia | uncommon |  |  | x | x | 
| Bronchospasm paradoxical | Bronchospasm paradoxical | postmarketing, uncommon |  | x | x | x | 
| Cardiac disorder | Cardiac disorder | postmarketing |  |  | x | x | 
| Mediastinal disorder | Mediastinal disorder | postmarketing |  | x | x | x | 
| Nervous system disorder | Nervous system disorder | postmarketing |  | x | x | x | 
| Skin disorder | Unspecified disorder of skin and subcutaneous tissue | postmarketing |  |  | x | x | 
| Anaemia | Anaemia |  |  |  |  | x | 
| Angina pectoris | Angina pectoris |  |  | x |  |  | 
| Bronchospasm | Bronchospasm |  |  |  |  | x | 
| Infection | Infection |  |  | x | x | x | 
| Connective tissue disorder | Connective tissue disorder |  |  | x | x | x | 
| Dyspnoea | Dyspnoea |  |  | x |  |  | 
| Hypokalaemia | Hypokalaemia |  |  |  | x | x | 
| Immune system disorder | Immune system disorder |  |  |  | x |  | 
| Pneumonia | Pneumonia |  |  | x |  |  | 
| Tremor | Tremor |  |  |  | x | x | 
| Vertigo | Vertigo |  |  |  |  | x | 
| Chest discomfort | Chest discomfort |  |  |  |  | x | 
| Asthma | Exacerbation of asthma |  |  | x |  |  | 
| Chronic obstructive pulmonary disease | COPD exacerbation |  |  | x |  |  | 
| Infestation | Infestation NOS |  |  | x | x | x | 
	 
 
  Indications
	Information about indications was extracted from the indications and usage sections of the labels.
	
 
	  
	  
		| Side effects: | 32 | 
|---|
		| Source: | FDA Structured Product Label | 
|---|
		 
	  
	  
		| Side effects: | 36 | 
|---|
		| Source: | EMA | 
|---|
		 
	  
	  
		| Side effects: | 39 | 
|---|
		| Source: | medicines.org.au | 
|---|
		 
	  
  
 
  
	Color scheme:
	  
	  standard – alternative
	  
	
	
|  |  | 100% | 
|  |  | 75% | 
|  |  | 50% | 
|  |  | 10% | 
|  |  | frequent (1% to 100%) | 
|  |  | infrequent (0.1% to 1%) | 
|  |  | rare (<0.1%) | 
|  |  | postmarketing | 
|  |  | 0% | 
|  |  | no frequency information | 
|  |  | not found on label |